Panacea Biotec Limited Launches DE NSTAR Project to Advance Dengue Vaccine Licensure in Sub-saharan Africa

Panacea Biotec Limited (NSE: PANACEABIO) launches DE NSTAR project to advance dengue vaccine DengiA/1 licensure in Sub-Saharan Africa.